Literature DB >> 26691189

[Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma].

Oh Sang Kwon1, Seong Han Choi1, Ju Hyun Kim1.   

Abstract

Inflammation is one of the most prominent characteristic features of chronic liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Most of HCC cases develop in patients with cirrhosis and cirrhosis develops in patients with chronic liver inflammation. Therefore, there is no doubt that there exist some strong connection among inflammation, fibrosis, and cancer. In fact, chronic unresolved inflammation is associated with persistent hepatic injury and concurrent regeneration, leading to sequential development of fibrosis, cirrhosis, and eventually HCC. This review will discuss the common mechanism of inflammation and fibrosis in chronic liver diseases, and then demonstrate why HCC develops in inflammatory and fibrotic conditions.

Entities:  

Keywords:  Cirrhosis; Fibrosis; Hepatocellular carcinoma; Inflammation

Mesh:

Substances:

Year:  2015        PMID: 26691189     DOI: 10.4166/kjg.2015.66.6.320

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  4 in total

1.  Effects of sub-chronic exposure to atmospheric PM2.5 on fibrosis, inflammation, endoplasmic reticulum stress and apoptosis in the livers of rats.

Authors:  Ruijin Li; Mei Zhang; Ying Wang; Ken Kin Lam Yung; Ruijun Su; Zhuoyu Li; Liping Zhao; Chuan Dong; Zongwei Cai
Journal:  Toxicol Res (Camb)       Date:  2018-01-10       Impact factor: 3.524

2.  The effect of vitamin D supplementation on the progression of fibrosis in patients with chronic liver disease: A protocol for a systematic review and meta-analysis.

Authors:  Tiantian Chen; Xiaohong Zuo; Shengju Wang; Penglong Yu; Jie Yuan; Shujun Wei; Jiayi Chen; Yue Sun; Yongxiang Gao; Xueping Li
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

3.  A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma.

Authors:  Chang-Liang Luo; Yuan Rong; Hao Chen; Wu-Wen Zhang; Long Wu; Diao Wei; Xiu-Qi Wei; Lie-Jun Mei; Fu-Bing Wang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

4.  Immune-related biomarkers shared by inflammatory bowel disease and liver cancer.

Authors:  Thong Ba Nguyen; Duy Ngoc Do; Thuy T P Nguyen; Truc Ly Nguyen; Tung Nguyen-Thanh; Ha Thi Nguyen
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.